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Abstract
Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and the
second cancer killer in China. The initiation and malignant transformation of cancer result from
accumulation of genetic changes in the sequences or expression level of cancer-related genes. It is of
particular importance to determine gene expression profiles of cancers on a global scale. SAGE and
LongSAGE have been developed for this purpose.
Methods: We performed SAGE in normal liver and HCC samples as well as the liver cancer cell line
HepG2. Meanwhile, the same HCC sample was simultaneously analyzed using LongSAGE. Computational
analysis was carried out to identify differentially expressed genes between normal liver and HCC which
were further validated by real-time quantitative RT-PCR.
Results: Approximately 50,000 tags were sequenced for each of the four libraries. Analysis of the
technical replicates of HCC indicated that excluding the low abundance tags, the reproducibility of SAGE
data is high (R = 0.97). Compared with the gene expression profile of normal liver, 224 genes related to
biosynthesis, cell proliferation, signal transduction, cellular metabolism and transport were identified to be
differentially expressed in HCC. Overexpression of some transcripts selected from SAGE data was
validated by real-time quantitative RT-PCR. Interestingly, sarcoglycan-ε (SGCE) and paternally expressed
gene (PEG10) which is a pair of close neighboring genes on chromosome 7q21, showed similar enhanced
expression patterns in HCC, implicating that a common mechanism of deregulation may be shared by
these two genes.
Conclusion: Our study depicted the expression profile of HCC on a genome-wide scale without the
restriction of annotation databases, and provided novel candidate genes that might be related to HCC.
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Background
Being a worldwide malignant liver tumor, hepatocellular
carcinoma (HCC) ranks the fifth in frequency among
common human solid tumors and the fourth leading
cause of cancer-related death [1,2]. The majority of HCC
cases occur in Asia and Sub-Saharan Africa, but incidence
has been increasing in Western Europe and the United
States in recent years [3,4]. In China, HCC is now the sec-
ond cancer killer [5]. Numerous studies have been carried
out in an effort to elucidate molecular mechanism of
hepatocarcinogenesis, metastasis and/or prognosis. Mul-
tiple genes have been reported to be involved in the devel-
opment of HCC. For instance, mutations of p53, β-catenin
and AXIN1 [6-10], activation of oncogenes such as c-myc,
c-met, c-jun, N-ras and nuclear factor κB [11-16], and up-
regulation of a set of genes including GPC3, LCN2, and
IGFBP-1 were observed in a certain number of HCC cases
[17-19]. These studies contributed greatly to our under-
standing of HCC in terms of individual molecules.
It is well known that the initiation and malignant trans-
formation of cancer result from accumulation of genetic
changes in the sequences or expression level of cancer-
related genes. Thus it is of particular importance to deter-
mine gene expression profiles of cancers on a global scale.
Several techniques have been developed for this purpose.
Serial Analysis of Gene Expression (SAGE) allows quanti-
tative measurement of gene expression profile through
sequencing of short tags. Compared with microarrays, the
expression profiles obtained by SAGE is exploratory in
nature as it is not restricted to available annotations. It has
been widely used in cancer studies since it was first intro-
duced by Velculescu et al. in 1995 [20]. Saha et al. further
developed LongSAGE which detects 21-bp tags instead of
the original 14-bp tags, thus making it feasible to directly
map the LongSAGE tags to genomic sequence data [21].
In the present study, we employed SAGE to comprehen-
sively analyze gene expression profiles of normal human
liver, HCC and the liver cancer cell line HepG2. The same
HCC sample was further analyzed simultaneously using
LongSAGE. To the best of our knowledge, there is no
SAGE or LongSAGE expression profile of HCC available in
the public domain. Our study provided a wealth of infor-
mation on HCC expression profile, and comparative anal-
ysis of datasets of HCC vs normal liver led to the
identification of a series of differentially expressed genes.
The following real-time quantitative RT-PCR analysis fur-
ther identified novel candidate genes potentially involved
in hepatocarcinogenesis of HCC.
Methods
Cell culture and tissue samples
Human HCC cell line HepG2 was cultured in Dulbecco's
modified Eagle's medium (Invitrogen, Carlsbad, CA) with
10% fetal bovine serum under 5% CO2 in a humidified
incubator at 37°C. Cells were harvested at 80–90% con-
fluence. Normal liver tissue was obtained from a patient
who underwent hepatectomy because of hepatic heman-
gioma. Clinical HCC samples and corresponding non-
tumorous liver tissues were derived from HCC patients
and kept frozen in liquid nitrogen immediately after sep-
aration. All samples were collected with informed consent
in accordance with the standards of Institutional Human
Subjects Protection Review Board.
SAGE and LongSAGE
Total RNAs were extracted from HepG2 and liver tissues
using TRIzol reagent (Invitrogen, Carlsbad, CA) and then
treated with DNaseI (Rhoch Diagnostics, Almere, The
Netherlands) according to the manufacture's protocol.
Polyadenylated mRNAs were then isolated using Oligotex
Direct mRNA Midi Kit (QIAGEN). Three SAGE libraries
were constructed starting with 200 ng polyA+ mRNA from
HepG2, normal liver tissue and HCC tissue respectively
according to SAGE protocol [20,22]. LongSAGE was per-
formed with the same amount of polyA+ mRNA from the
same HCC tissue used in SAGE following the procedures
described previously [21]. Sequencing of SAGE and Long-
SAGE tags were carried out using BigDye Terminator Cycle
Sequencing Kits and ABI 3700 DNA Sequencers (Applied
Biosystems, Foster City, CA). The sequence and frequency
of 14-bp tags from SAGE and 21-bp tags from LongSAGE
were extracted from the raw sequence files of concate-
nated di-tags using SAGE2000 analysis software version
4.5 (kindly provided by Dr. K. Kinzler, Johns Hopkins
University School of Medicine).
Computational Analysis
To exclude sequencing errors, only tags detected at least
twice in the four SAGE libraries (three SAGE libraries and
one LongSAGE library) were included for further analysis.
SAGEmap reliable mapping (http://www.ncbi.nlm.nih.go
v/SAGE, UniGene Build #182) [23] was used to establish
tag-to-gene assignments. Comparison analysis between
SAGE libraries was performed using the IDEG6 software
http://telethon.bio.unipd.it/bioinfo/IDEG6/[24]. Differ-
entially expressed tags were selected according to the cut-
off threshold (p value < 0.05, fold change > 3) calculated
according to pairwise comparison algorithm [25]. The
Cluster and Treeview programs were used to generate the
average linkage hierarchical clustering and visualize
changes of gene expression [26]. Functional classification
of genes was performed using DAVID program http://
david.abcc.ncifcrf.gov/ obtained from NIAID (National
Institute of Allergy and Infectious Disease).
Real-time quantitative RT-PCR
Total RNAs were extracted from HCC samples and corre-
sponding nontumorous liver tissues using TRIzol reagentBMC Medical Genomics 2009, 2:5 http://www.biomedcentral.com/1755-8794/2/5
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(Invitrogen) followed by treating with DNaseI according
to the manufacture's protocol. 2 μg of total RNA was
reverse transcribed in a total volume of 20 μl containing
200 units of SuperScript II RNase H- Reverse Transcriptase
(Invitrogen), 50 mM Tris-HCl (pH8.3), 75 mM KCl, 3
mM MgCl2, 10 mM dithiothreitol, 500 μM dNTPs each,
500 ng oligo(dT)23 primer and 40 units of RNaseOUT at
42°C for 50 min, followed by inactivating at 70°C for 15
min.
For real-time quantitative RT-PCR, 1 μl of the first strand
cDNA and 5 μl of 2× SYBR Green PCR mix (Applied Bio-
systems, Foster City, CA) was added to a final volume of
10 μl. The thermal cycles were performed on LightCycler
(Roche) following conditions at 95°C for 30 s, 40 cycles
at 95°C for 5 s, 60°C for 5 s and 72°C for 30 s. Each reac-
tion was performed in triplicate. The threshold cycle (Ct)
value was used to calculate the expression ratio of target
genes to internal control gene (GAPDH) with the formula
2Ct(GAPDH)-Ct(target gene). Two-side student's t  test was
applied in the statistical analysis of quantitative RT-PCR
data.
All the sequences of differently expressed transcripts were
obtained from GenBank http://www.ncbi.nlm.nih.gov/
Genbank/index.html. PCR Primers were designed using
Primer 3.0 http://frodo.wi.mit.edu/. One set of primers
were also designed for GAPDH which is considered an
internal control for RT-PCR. The sequences of primers for
each transcript were listed in Table 1.
Results
Summary of SAGE data
A total of 56,984, 63,800 and 47,149 tags were detected
from the normal liver, HCC and HepG2 SAGE libraries
respectively, and 51,632 tags were obtained from the HCC
LongSAGE library. Approximately 31%~34% of the total
tags of each SAGE library were unique, while unique tags
accounted for 45% of total tags of the HCC LongSAGE
library (Table 2). When using SAGEmap to annotate these
tags, we found that about 50% of unique tags in a SAGE
library matched to specific genes (single match), 25~28%
to multiple genes (multiple match) and 22~25% were
novel tags that do not match to any known genes. The pat-
tern was quite different in the LongSAGE library, with
43% of unique tags being single matched tags, 3.5% mul-
tiple matched tags and 53% novel tags. The result indi-
cated that by extending the tag length from 14 to 21 bp,
the specificity of SAGE tags was substantially improved.
More than 70% of total tags in each library were single
copy tags, while tags with high copy numbers (> 5 copies)
account for less than 10% of the total tags (Table 3). This
result is consistent with the fact that the majority of
human genes are expressed at low levels [27].
Correlation analysis of SAGE data
As one set of SAGE data of normal liver is available in the
public Gene Expression Omnibus database (http://
www.ncbi.nlm.nih.gov/geo/, accession number
GSM785), we compared our data of normal liver with it
to evaluate the correlation between these two independ-
ent libraries. The result indicated that the data from public
Table 1: Sequences of primers used in RT-PCR
Unigene GenBank
Accession No.
Product
Size
Primers
GAPDH NM_002046 106 bp F:ATGGGTGTGAACCATGAGAAG
R:AGTTGTCATGGATGACCTTGG
CCL20 BC020698 200 bp F:GCGCAAATCCAAAACAGACT
R:CAAGTCCAGTGAGGCACAAA
S100P BC006819 116 bp F:TACCAGGCTTCCTGCAGAGT
R:AGCCACGAACACGATGAACT
PEG10 NM_015068 111 bp F:TCCTGTCTTCGCAGAGGAGT
R:TTCACTTCTGTGGGGATGGA
SGCE NM_003919 220 bp F:ATGCAAACACCAGACATCCA
R:TCTGATGTGGCAAGTTCTGC
XAGE-1 AF251237 159 bp F:TCTGCAAGAGCTGCATCAGT
R:AGCTTGCGTTGTTTCAGCTT
COL4A1 NM_001845 228 bp F:ACGGGGGAAAACATAAGACC
R:TGGCGCACTTCTAAACTCCT
ZFYVE1 NM_178441 213 bp F:AACTGCTACGAAGCCAGGAA
R:GTTGTGGCAGTGGAGGATTT
ZNF83 BC050407 224 bp F:TGGGAAGGTCTTCGGTCTAA
R:CGGCATGAAATCTCTGATGA
TNPO2 NM_013433 213 bp F:GGCGTTGTGCAGGACTTTAT
R:GGCAGTCTCCATGATCACCT
TM4SF1 NM_014220 169 bp F:AGGGCCAGTACCTTCTGGAT
R:AAGCCACATATGCCTCCAAGBMC Medical Genomics 2009, 2:5 http://www.biomedcentral.com/1755-8794/2/5
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database correlated well with our data, with Pearson's cor-
relation coefficient 0.74 (Figure 1A).
We also compared the SAGE and LongSAGE data which
were obtained from the same HCC tissue sample of the
same patient. We extracted the 14-bp SAGE tags from the
21-bp LongSAGE tags. The converted SAGE library could
be considered as a technical replicate. Totally 6,815 over-
lapping tags were detected between these two libraries.
Thus among the 20,313 unique tags in the original SAGE
library, only 33.5% of them are detected by the second
library derived from LongSAGE tags. Most of the missed
tags are low abundance tags for which detection by ran-
dom sampling is a stochastic process. Another reason
might be possible sequencing errors that resulted in many
singleton tags. However, analysis of these overlapping
tags showed remarkable consistency between these two
libraries with Pearson's correlation coefficient 0.97 (Fig-
ure 1B). This result reassured us the reproducibility of
SAGE method on measuring gene expression.
We further compared the data of HCC with that of HepG2
to find out how much the gene expression profile has
changed in cell line comparing with the HCC tissue. The
difference between HCC and HepG2 was very notable,
with Pearson's correlation coefficient 0.55, even greater
than difference between HCC and normal liver (Pearson's
correlation coefficient 0.70) (Figure 1C and 1D). This
result suggested that the gene expression profile of cell
line has changed too much to be regarded as the reference
of its corresponding tissue.
Identification and functional analysis of genes 
differentially expressed between normal liver and HCC
In order to identify genes differentially expressed between
normal liver and HCC, we used the IDEG6 software to
compare the normal liver library with both the HCC
library and the second HCC library derived from Long-
SAGE. Only genes consistently up-regulated or down-reg-
ulated in both comparisons were considered to be
differentially expressed. Totally 224 genes were identified
to be differentially expressed, with the significance p <
0.05 and fold change > 3 (Additional file 1). Figure 2
shows the expression patterns of these altered genes in
normal liver, HCC and HepG2. The top 20 up-regulated
and down-regulated genes ranked by fold change were
listed in Table 4 and Table 5 respectively. Consistent with
previous results [18,28], our data also indicated that
GPC3 gene was significantly up-regulated in HCC with
fold change of 69. Among the 224 differentially expressed
Table 2: Tag counts of SAGE and LongSAGE libraries
Total Unique
(%)
Single matched
(%)
Multiple matched
(%)
Novel
(%)
Normal Liver 56,984 17,719
(31.1)
8,823
(49.8)
4,452
(25.1)
4,444
(25.1)
HepG2 47,149 15,827
(33.6)
7,956
(50.2)
4,427
(28.0)
3,444
(21.8)
HCC 63,800 20,313
(31.8)
10,048
(49.4)
5,375
(26.5)
4,890
(24.1)
HCC LongSAGE 51,632 23,093
(44.7)
9,973
(43.2)
801
(3.5)
12,319
(53.3)
Table 3: Frequency distributions of unique tags from the SAGE and LongSAGE libraries
Tag copy No. Normal Liver
(%)
HepG2
(%)
HCC
(%)
HCC LongSAGE
(%)
1 12,842
(72.5)
11,223
(71.0)
14,477
(71.3)
18,171
(78.7)
2 2,123 2,015 2,495 2,205
3 872 847 1,002 947
4 447 429 558 469
5–10 864 837 1,083 823
11–20 291 248 364 256
21–99 231 166 268 180
100 and > 49 62 66 42
Total 17,719 15,827 20,313 23,093BMC Medical Genomics 2009, 2:5 http://www.biomedcentral.com/1755-8794/2/5
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genes, the expression level of 104 genes was significantly
higher in HCC than in normal liver (p < 0.05), while 120
genes was significantly lower in HCC (p < 0.05). In addi-
tion to these 224 annotated tags, our list of differentially
expressed tags also includes 99 tags that could be matched
to multiple genes, and 109 tags that were differentially
expressed but could not be mapped to any known gene
(data not shown). Some of these novel tags are extremely
highly expressed in HCC. For example, the tag TAAGTTT-
GGG is detected 24 and 17 times in two HCC libraries but
is not detected at all in the other two libraries. It will be of
interest to further study these tags. In the current study,
however, we will focus on the annotated tags.
Functional analysis of the 224 differently expressed genes
was performed using DAVID program. The 104 up-regu-
Correlation analysis of SAGE and LongSAGE libraries Figure 1
Correlation analysis of SAGE and LongSAGE libraries. (A) Correlation between normal liver SAGE data from public 
database ftp://ftp.ncbi.nlm.nih.gov/pub/sage/obsolete/seq/ and our own normal liver data. Pearson's correlation coefficient 0.74. 
(B) Correlation between SAGE and LongSAGE data of HCC. Pearson's correlation coefficient 0.97. (C) Correlation between 
HCC and HepG2 SAGE data. Pearson's correlation coefficient 0.55. (D) Correlation between HCC and our own normal liver 
SAGE data. Pearson's correlation coefficient 0.70.
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lated genes were grouped into eight functional clusters
and one unclassified cluster (Additional file 2). These
genes activated in HCC were involved in biological proc-
esses of biosynthesis, cell proliferation, signal transduc-
tion, transport, response to external stimulus, and cellular
metabolism et al. Genes related to biosynthesis include 10
ribosomal proteins. Consistent with our observation,
increased expression pattern of ribosomal proteins in
HCC were demonstrated by previous studies [29,30].
Genes participate in cell proliferation and signal transduc-
tion processes, such as MCM7  and  IGFBP1  were also
reported to be up-regulated in HCC by other groups
[31,32].
The 120 down-regulated genes were assembled into seven
functional Gene Ontology (level 3) categories including
blood coagulation, cell death, cellular metabolism, trans-
port, signal transduction et al., and one unclassified group
(Additional file 3). We also tested the over-representation
of GO terms of all levels in this list. The most significant
cluster is 8 genes belongs to a subcategory related to acute
inflammatory response with p < 0.0005 after Benjamini
correction of multiple testing. This cluster includes comple-
ment factor I (CFI) and several genes (C1S, C1QA, and
C8B) encoding subcomponents of complement compo-
nent 1 and 8. Another significantly enhanced cluster
includes 6 genes related to blood coagulation (p < 0.03).
These results indicated the loss of liver function in HCC.
Taken together, functional classification of genes differen-
tially expressed in HCC revealed dysregulated pathways
which may contribute to the disease. Similar to our
results, microarray studies carried out by other groups also
indicated genes involved in protein biosynthesis and cell
signaling were up-regulated in HCC, while genes
expressed at lower level in HCC included complement
proteins and clotting factors [33,34]. Thus, data obtained
from SAGE and microarray methods could cross-validate
each other and reveal some consistent events in HCC
despite its heterogeneity.
Validation of differentially expressed genes
To validate the differently expressed genes identified by
SAGE, real-time quantitative RT-PCR analysis was per-
formed in 20 pairs of HCC and adjacent nontumorous
l i v e r  t i s s u e s .  T o t a l l y  1 0  g e n e s  f r o m  S A G E  d a t a  w e r e
selected for examination. CCL20 and S100P were signifi-
cantly up-regulated in HepG2 but not in HCC data, while
ZFYVE1, PEG10, SGCE, XAGE-1, COL4A1, ZNF83,
TNPO2  and  TM4SF1  were up-regulated in HCC data.
SAGE tag abundance of these genes was listed in Table 6.
SGCE  was not included in the list of 224 differently
expressed genes which were derived only from single
matched tags, because the tag matched to SGCE was a
multiple matched tag. Notably, SGCE locates on chromo-
Hierarchical clustering for genes differentially expressed in  HCC Figure 2
Hierarchical clustering for genes differentially 
expressed in HCC. For visual comparison, genes differen-
tially expressed in HCC and normal liver were clustered by 
Treeview program. The expression pattern of these genes in 
HepG2 was also shown. The red color represents genes up-
regulated, and the green color represents genes down-regu-
lated. 1: normal liver, 2: normal liver from public database, 3: 
HCC SAGE, 4: HCC LongSAGE, 5: HepG2.
-3 -2 1 0 1 2 3
Normalized expressionBMC Medical Genomics 2009, 2:5 http://www.biomedcentral.com/1755-8794/2/5
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Table 4: Top 20 genes up-regulated in HCC
Tag UniGene Symbol Name Function Fold Change
ACCCGCCGGG Hs.335106 ZFYVE1 Zinc finger, FYVE domain containing 1 Transport 81
GATTTCTTTG Hs.435036 GPC3 Glypican 3 extracellular matrix 69
GCCAAGAATC Hs.307720 DTNB Dystrobrevin, beta Calcium and Zinc ion binding 56
CTAACTAGTT Hs.473583 NSEP1 Nuclease sensitive element binding protein 1 Response to external stimulus 50
GCTTGAATAA Hs.116724 AKR1B10 Aldo-keto reductase family 1, member B10 
(aldose reductase)
Steroid metabolism 47
GTGACCACGG Hs.436980 GRIN2C Glutamate receptor, ionotropic, N-methyl D-
aspartate 2C
Ion transport 39
CTCATCCTAC Hs.416049 TNPO2 Transportin 2 (importin 3, karyopherin beta 2b) Protein transport 36
GATGTATGTG Hs.461085 EST, strongly similar to NP_775842.1 Unclassified 36
ACCAGCACTC Hs.436911 AMBP Alpha-1-microglobulin/bikunin precursor Signal Transduction 32
CCGACGGGCG Hs.198161 PLA2G4B Phospholipase A2, group IVB (cytosolic) Signal Transduction 32
GGTCAGTCGG Hs.409352 FLJ20701 Hypothetical protein FLJ20701 Unclassified 29
ATGTAAAAAA Hs.429608 C5orf18 Chromosome 5 open reading frame 18 Unclassified 28
GACCCACCAT Hs.436911 AMBP Alpha-1-microglobulin/bikunin precursor Signal Transduction 28
CAAGTTTGCT Hs.439552 EEF1A1 Eukaryotic translation elongation factor 1 alpha 1 Signal Transduction 26
TTGTAAACTT Hs.509226 FKBP3 FK506 binding protein 3, 25kDa Cellular metabolism 25
GAAGGTGATC Hs.112208 XAGE-1 X antigen family, member 1 Cellular metabolism 25
GGGACGAGTG Hs.351316 TM4SF1 Transmembrane 4 L six family member 1 Unclassified 21
GAGGGTGGCG Hs.473847 SH3BGR SH3 domain binding glutamic acid-rich protein Cellular metabolism 18
TAAATACAGT Hs.221497 PRO0149 PRO0149 protein Unclassified 18
GTGGATGGAC Hs.6418 GPR175 G protein-coupled receptor 175 Organogenesis 17
Table 5: Top 20 genes down-regulated in HCC
Tag UniGene Symbol Name Function Fold Change
GGCAGAGCCT Hs.1955 SAA2 Serum amyloid A2 Response to external stimulus 56
TTAACTTTAT Hs.368626 RTN1 Reticulon 1 Signal Transduction 56
TAAGCCCCGC Hs.2899 HPD 4-hydroxyphenylpyruvate dioxygenase Cellular metabolism 49
GACACCGAGG Hs.333383 FCN3 Ficolin (collagen/fibrinogen domain 
containing) 3 (Hakata antigen)
Transport 44
TTGGCTAGAC Hs.100914 Cep192 Centrosomal protein 192 kDa Unclassified 40
TTCCAGAGGC Hs.8821 HAMP Hepcidin antimicrobial peptide Cellular metabolism 38
GATCCCAACT Hs.418241 MT2A Metallothionein 2A Metal Ion Binding 37
AAGGACGCCG Hs.117367 SLC22A1 Solute carrier family 22 (organic cation 
transporter), member 1
Transport 37
AACTCACAGA Hs.168718 AFM Afamin Transport 36
AGAATAAGAA Hs.418167 ALB Albumin Regulation of body fluid 
(Blood coagulation)
26
GCGGCCCCCC Hs.839 IGFALS Insulin-like growth factor binding protein, 
acid labile subunit
Signal Transduction 24
TACAGCCTGT Hs.406184 FGFR1OP2 FGFR1 oncogene partner 2 Unclassified 24
CTTGGGTTTT Hs.355888 PLCB2 Phospholipase C, beta 2 Lipid metabolism 24
CACTTCAAGG Hs.521903 LY6E Lymphocyte antigen 6 complex, locus E Signal Transduction 23
CCACCCCGAA Hs.35052 TEGT Testis enhanced gene transcript 
(BAX inhibitor 1)
Cell Death 22
CCATTACCTC Hs.134958 RODH-4 Retinol dehydrogenase 16 
(all-trans and 13-cis)
Lipid metabolism 21
AGTCTGGCCT Hs.416707 ABCA4 ATP-binding cassette, sub-family A (ABC1), 
member 4
Response to external stimulus 21
CCAGCAAGAG Hs.11900 ZGPAT Zinc finger, CCCH-type with G patch 
domain
Unclassified 20
AGAACCTTCC Hs.181244 HLA-A Major histocompatibility complex, class I, A Antigene presentation 19
CCCTTCTTTG Hs.356368 HAO2 Hydroxyacid oxidase 2 (long chain) Cellular metabolism 19BMC Medical Genomics 2009, 2:5 http://www.biomedcentral.com/1755-8794/2/5
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some 7q21 together with PEG10 in a head-to-head man-
ner, separated by only 115 base pairs between the 5' ends
of these two genes. Among these genes, CCL20 and PEG10
have been demonstrated to be up-regulated in HCC by
other groups [35-37], and were used as positive controls
in our study. XAGE-1, COL4A1, S100P and TM4SF1 were
observed to show elevated expression in various cancers,
but the expression level of these genes in HCC has not
been reported previously [38-43]. The possible associa-
tion existing between ZNF83, TNPO2, ZFYVE1 and cancer
was discussed in the present study for the first time.
By real-time quantitative RT-PCR analysis, increased
expression was confirmed in 8 of these 10 genes. As
shown in Figure 3, CCL20, S100P, PEG10, SGCE, XAGE-1,
COL4A1, ZNF83, and TM4SF1 was significantly up-regu-
lated in HCC compared to the corresponding nontumor-
ous liver (p < 0.05). Expression level of PEG10 and SGCE
was further examined in more samples (totally 32 pairs of
HCC and corresponding nontumorous liver). Similar
expression patterns of these two genes were observed in
HCC, with Pearson's correlation coefficient 0.71 (Figure
4). No significant differences in expression level of
TNPO2 and ZFYVE1 was detected between HCC and adja-
cent nontumorous liver, reflecting the heterogeneous fea-
ture of HCC. These results further validated the
quantitative data of SAGE profiles and provided novel
candidate genes which may help to illustrate the molecu-
lar mechanism of hepatocarcinogenesis.
Discussion
In this study, we applied SAGE to analyze gene expression
profiles of normal liver, HepG2 and HCC on the genome
scale. LongSAGE was also carried out to analyze the same
HCC sample. From our results we found that the propor-
tion of unique tags was higher in the HCC LongSAGE
library (45%) than in the SAGE library (32%), suggesting
that LongSAGE is definitely more efficient in detecting
unique tags and tag-to-gene mapping than SAGE. Among
the 20,313 unique tags in the HCC SAGE library, 6,815
(33.5%) of them were detected by LongSAGE tags with
high correlation (Pearson's correlation 0.97). This indi-
cated that the data of SAGE is repeatable even by Long-
SAGE. Thus it is reasonable that Pearson's correlation
observed between our normal liver data and those in the
public database was as high as 0.74 although they were
obtained from totally independent experiments. We
could draw a conclusion from these results that compari-
son among SAGE data produced by different labs is prac-
tical and reliable because of the high repeatability of SAGE
technique.
It is not to our surprise that HepG2, a cultured hepatocel-
lular carcinoma cell line, exhibited a different gene expres-
sion pattern compared to the pattern of HCC. Within
passage cells, a lot of changes might have occurred on the
genome scale which would subsequently affect the gene
expression level. Relatively low correlation (Pearson's cor-
relation coefficient 0.55) was observed between HepG2
and HCC in our SAGE data set. This result suggested that
the expression profile of cultured cells should be cau-
tiously used as reference of the corresponding tissue.
However, analysis of HepG2 data still could provide some
useful clues in identifying genes differentially expressed
between normal liver and HCC. For example, increased
expression of both CCL20 and S100P genes were detected
in HCC by quantitative RT-PCR, although they were
found to be significantly up-regulated only in HepG2 but
not in HCC SAGE data. Consistent with our result, recent
studies carried out by Rubie et al indicated that CCL20 was
activated in HCC and supposed to be involved in hepato-
carcinogenesis [35,36]. Up-regulation of S100P  was
reported in breast cancer, prostate cancer and early-stage
non-small cell lung cancer [38-40], and it was also sug-
gested to be a key factor in the aggressiveness of pancreatic
cancer and promote cancer growth, survival and invasion
[41]. Our results indicated that S100P was up-regulated in
HCC, suggesting a possible role of S100P may play in liver
cancer.
Table 6: SAGE tag abundance of selected genes
Tag Counts (Tag Per Million)
Tag Unigene Normal liver HCC HCC-Long HepG2
GAGGGTTTAG CCL20 25 23 5 844
TACCTCTGAT S100P 25 23 5 1091
GAAGGTGATC XAGE-1 5 224 286 5
GACCGCAGGA COL4A1 5 188 146 5
ACCCGCCGGG ZFYVE1 5 553 1107 203
ATTTTGTCGT ZNF83 5 188 122 5
CTCATCCTAC TNPO2 5 315 427 5
GAAGTTATAA TM4SF1 25 169 685 499
GAAGTTATAA PEG10 5 133 216 128
TTGGCAGTAT SGCE; DDX43 25 242 263 30BMC Medical Genomics 2009, 2:5 http://www.biomedcentral.com/1755-8794/2/5
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Enhanced expression of COL4A1, TM4SF1, XAGE-1,
ZNF83, PEG10 and SGCE in HCC was detected by our
SAGE data, and further validated by real-time quantitative
RT-PCR. Potential roles of COL4A1, TM4SF1, and XAGE-
1 in various cancers have been demonstrated including
oral squamous cell carcinomas, gastric cancer, breast can-
cer and lung cancer et al, but not liver cancer [42-44]. Our
results gave a clue to the probability that these genes may
also play a role in HCC pathogenesis. The maternally
imprinted gene PEG10 was recently identified as a poten-
tial biomarker for HCC diagnosis, and genomic gain
accounts for the major cause of its up-regulation in HCC
[37]. SGCE was also a maternally imprinted gene, locating
on chromosome 7q21 as close as 115 base pairs apart
from PEG10 in a head-to-head manner. Due to the origi-
nal SAGE tag TTGGCAGTAT matched to SGCE  and
DDX43 (DEAD box polypeptide 43) gene simultaneously, it
was not included in our later analysis of differentially
expressed genes in HCC which were derived only from
single matched SAGE tags. However, PEG10 and SGCE
were demonstrated to be up-regulated in a parallel way in
B-cell chronic lymphocytic leukemia patients [45]. We
examined the expression of these two genes in HCC and
found that PEG10 and SGCE show similar expression pat-
terns with close correlation (Pearson's correlation coeffi-
cient 0.71), pointing towards the possibility that these
two genes may share common mechanism of deregula-
tion in HCC. Whether PEG10 and SGCE are co-regulated
via chromosome amplification at the 7q21 locus or their
common promoter region is under investigating by our
further study.
Conclusion
In summary, this study depicted the expression profile of
HCC using both SAGE and LongSAGE techniques, which
would provide valuable clues for understanding of molec-
Real-time quantitative RT-PCR validation of SAGE data Figure 3
Real-time quantitative RT-PCR validation of SAGE data. Expression level of candidate genes identified to be up-regu-
lated in HCC or HepG2 by SAGE data was examined in 20 pairs of HCC and corresponding nontumorous liver tissues by 
quantitative RT-PCR. Increased expression level in HCC was observed in CCL20, COL4A1, XAGE-1, PEG10, SGCE, S100P, 
TM4SF1 and ZNF83 genes (p < 0.05). Red bars represent expression level of HCC tissues, blue bars represent nontumorous 
liver tissues, and horizontal bars represent SD values.
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ular mechanism of HCC. Further investigations are
needed for the candidate genes suggested by this study,
especially for PEG10 and SGCE genes locating together on
chromosome 7q21, and for many of the tags highly
expressed in HCC but could not be matched to any
known genes.
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